Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Integrating hepatitis B virus, hepatitis C virus and human immunodeficiency virus screening for migrants from endemic countries into travel-related and sexual health care in Amsterdam, the Netherlands

Bibliographic Data

ID22073071
AuthorsEllen Generaal (0009-0002-8466-0403, Netherlands Center for Occupational Diseases, corresponding author), Yara Bachour (0000-0002-5321-9036, GGD Amsterdam), Sara Klijzing (GGD Amsterdam), Akke Cornelissen (GGD Amsterdam), Roel Toering (GGD Amsterdam), Elske Hoornenborg (0000-0002-0512-2109, GGD Amsterdam), Eline Op de Coul (0000-0002-8263-9187, National Institute for Public Health and the Environment), Nora Hamdiui (0000-0003-2861-7072, National Institute for Public Health and the Environment), Annemarie Meiberg (National Institute for Public Health and the Environment), Evelien Siedenburg (GGD Amsterdam), Maria Prins (0000-0003-2967-0289, Netherlands Center for Occupational Diseases)
Year2025
Volume13
Pages1636918-1636918
Publication date2025-09-02
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2025.1636918
PMID40963655
OpenAlexW4413929138
LanguageEN
References cited29

Introduction: The Health Council of the Netherlands has recommended screening for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) for migrants born in countries endemic for these infections. We investigated the operational feasibility, test uptake and diagnostic outcomes of integrated HBV/HCV/HIV screening into routine care at the Public Health Service (PHS) of Amsterdam. Methods: In 2022-2023, visitors born in endemic countries (≥ 18 years) were offered free HBV, HCV and HIV testing at the Travel and Vaccination Center (TVC) of the PHS. In 2021-2022, 1,172 visitors born in an endemic country for HCV (≥ 16 years) were offered free HCV testing at the Center for Sexual Health (CSH), alongside standard free HBV/HIV testing. Countries considered endemic for HBV and HCV had a prevalence of ≥2.0% or ranked among the top-10 endemic countries in the Netherlands. The screening program was considered operationally feasible if inclusion began within six months and ≥25% (TVC) or ≥50% (CSH) of eligible visitors were included within one year. Positivity rate was considered 'low' for prevalence < 2.0%, and 'high' for prevalence ≥ 2.0%. Results: = 290) testing. At the CSH 1,023 visitors underwent HCV testing. Inclusion targets were met. Test uptake at the CSH was 87%; data for TVC were unavailable. At the TVC, we identified five newly diagnosed chronic HBV cases (2.0, 95%CI = 0.6-4.4%) and no new cases for HCV or HIV. At the CSH, one newly diagnosed chronic HCV case was identified (0.1, 95%CI = 0.01-0.5%). Discussion: Integrating HBV, HCV and HIV screening into routine travel-related care and additional HCV screening into sexual health care is operationally feasible. HBV screening at the TVC showed a high yield, while HCV and HIV yields were low. Routine HBV screening should be further examined in similar settings for migrants from endemic countries, preferably alongside HCV and HIV testing

Family medicine · Hepatitis B · Hepatitis B virus · Hepatitis C virus · Sexual behavior · Virus · Hepatitis B Virus Studies · HIV/AIDS Research and Interventions · Medicine · Travel-related health issues · Virology

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae